We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+3.58%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$69.4B
AUM Growth
+$3.54B
Cap. Flow
+$1.44B
Cap. Flow %
2.08%
Top 10 Hldgs %
21.44%
Holding
3,843
New
225
Increased
1,690
Reduced
1,576
Closed
217

Sector Composition

Rank Sector Weight
1 Technology 10.52%
2 Financials 9.29%
3 Healthcare 8.12%
4 Industrials 6.67%
5 Consumer Discretionary 5.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MIME
2701
DELISTED
Mimecast Limited
MIME
$467K ﹤0.01%
10,000
-4,402
-31% -$209K
CXE
2702
DELISTED
MFS High Income Municipal Trust
CXE
$466K ﹤0.01%
89,411
+1,978
+2% +$10.2K
BFO
2703
DELISTED
Blackrock Florida Municipal 2020 Term Trust
BFO
$466K ﹤0.01%
32,265
+16,000
+98% +$230K
ASA
2704
ASA Gold and Precious Metals
ASA
$1.1B
$465K ﹤0.01%
40,680
-7,533
-16% -$75.6K
SFL icon
2705
SFL Corp
SFL
$1.58B
$465K ﹤0.01%
37,190
+6,759
+22% +$85.4K
UPBD icon
2706
Upbound Group
UPBD
$1.12B
$465K ﹤0.01%
+17,453
New +$415K
ETX
2707
Eaton Vance Municipal Income 2028 Term Trust
ETX
$199M
$464K ﹤0.01%
22,540
+557
+3% +$11.5K
FOSL icon
2708
Fossil Group
FOSL
$317M
$464K ﹤0.01%
40,322
-16
-0% -$196
JGH icon
2709
Nuveen Global High Income Fund
JGH
$356M
$464K ﹤0.01%
30,025
-2,527
-8% -$39K
SFST icon
2710
Southern First Bancshares
SFST
$594M
$463K ﹤0.01%
11,824
-739
-6% -$26.8K
SIGI icon
2711
Selective Insurance
SIGI
$5.66B
$463K ﹤0.01%
6,186
+49
+0.8% +$3.49K
USO icon
2712
United States Oil Fund
USO
$1.78B
$463K ﹤0.01%
4,808
+1,550
+48% +$155K
IOVA icon
2713
Iovance Biotherapeutics
IOVA
$2.9B
$461K ﹤0.01%
+18,793
New +$283K
MTSC
2714
DELISTED
MTS Systems Corp
MTSC
$461K ﹤0.01%
7,876
-155
-2% -$8.63K
OPK icon
2715
Opko Health
OPK
$1.04B
$459K ﹤0.01%
188,050
+5,602
+3% +$12.2K
PHD
2716
DELISTED
Pioneer Floating Rate Fund
PHD
$459K ﹤0.01%
42,961
-1,920
-4% -$20.3K
SPFF icon
2717
Global X SuperIncome Preferred ETF
SPFF
$141M
$459K ﹤0.01%
39,491
+16
+0% +$186
THRM icon
2718
Gentherm
THRM
$1.27B
$459K ﹤0.01%
10,968
-661
-6% -$26.6K
ALFA
2719
DELISTED
AlphaClone Alternative Alpha ETF
ALFA
$459K ﹤0.01%
8,745
+446
+5% +$23K
QDF icon
2720
FlexShares Quality Dividend Index Fund
QDF
$2.27B
$458K ﹤0.01%
10,209
-3,770
-27% -$169K
ROAD icon
2721
Construction Partners
ROAD
$6.71B
$458K ﹤0.01%
30,493
-4,162
-12% -$54.3K
SPXX icon
2722
Nuveen S&P 500 Dynamic Overwrite Fund
SPXX
$343M
$456K ﹤0.01%
28,884
-363
-1% -$5.68K
JTA
2723
DELISTED
Nuveen Tax-Advantaged Total Return Strategy Fund
JTA
$456K ﹤0.01%
39,889
-648
-2% -$7.56K
LIT icon
2724
Global X Lithium & Battery Tech ETF
LIT
$1.6B
$455K ﹤0.01%
17,458
+1,628
+10% +$43.9K
JHY
2725
DELISTED
Nuveen High Income 2020 Target Term Fund Common Shares of Beneficial Interest
JHY
$455K ﹤0.01%
46,124
+3,266
+8% +$32.5K

Similar funds

Raymond James & Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Raymond James & Associates held 3,843 positions worth $69.4B, up 5.4% from $65.8B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q2 2019 filing shows 225 new, 1,690 increased, 1,576 reduced and 217 closed positions. Its largest new stake was Dow Inc: 851,378 shares worth $42M. The largest sale was AbbVie, an estimated $134M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2019 buy was Dow Inc: 851,378 shares worth $42M.
  • Raymond James & Associates added most to Medtronic in Q2 2019, an estimated $157M increase.
  • Raymond James & Associates's biggest Q2 2019 reduction was AbbVie, cutting an estimated $134M.
  • Raymond James & Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $5.43M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $69.4B portfolio in Q2 2019.
  • Raymond James & Associates opened 225 new positions and closed 217 in Q2 2019.
  • Raymond James & Associates's portfolio value rose 5.4% quarter-over-quarter to $69.4B.

Based on Raymond James & Associates's 13F filing for Q2 2019, filed 6 Aug 2019.